In most cases, unusual vaginal bleeding is caused by a hormonal imbalance

Indications and Usage Wegovy (semaglutide) injection is indicated in combination with a reduced calorie diet and increased physical activity: To reduce the risk of major adverse cardiovascular (CV) events (CV death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established CV disease and either obesity or overweight To reduce excess body weight and maintain weight reduction long term in: Adults and pediatric patients 12 years and older with obesity Adults with overweight in the presence of at least one weight-related comorbidity Wegovy (semaglutide) tablets are indicated in combination with a reduced calorie diet and increased physical activity to: Reduce the risk of major adverse cardiovascular (CV) events (CV death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established CV disease and either obesity or overweight Reduce excess body weight and maintain weight reduction long term in adults with obesity or with overweight in the presence of at least one weight-related comorbidity Limitations of Use: Concomitant use of Wegovy tablets or Wegovy injection with other semaglutide-containing products or with any GLP-1 receptor agonist is not recommended Reference Centers for Medicare and Medicaid Services

Specifically, here is how the average weight loss broke down, depending on dose: Additional research supports tirzepatide as effective for weight loss
This study does, however, have limitations typical of real-world data and we recognise the early exploratory nature of our work would benefit from further dedicated longitudinal studies with more robust design methodology in order to confirm our findings
Discovering a lump in the armpit is understandably concerning, but timely, informed steps help determine whether this is a temporary issue or something needing more thorough investigation